ESAB May Be About 30% Undervalued After Earnings-if Investors Stay Stuck on the EPS Miss

ESAB's latest quarter mixed optics with stronger sales

The market's first read on ESAB's latest quarter was the easiest one to grab: earnings missed. Non-GAAP EPS came in at $1.33, versus consensus of $1.37. In industrial earnings reports, that headline can dominate the reaction even when it tells only part of the story.

Revenue and mix are the better signals here

The more constructive operating signal came from sales. ESAB posted 12.9% year-over-year revenue growth and beat Wall Street's top-line expectation in the latest quarter. That does not erase the skepticism created by weaker growth over the prior two years, but it does suggest the business is not simply another industrial slowdown story.

If investors keep treating this as an EPS problem while underestimating the sales beat and the changing mix underneath it, the recent sell-off may be overshooting the fundamentals.

That is the why-now setup. ESAB shares are down 17.86% year to date and down 9.69% over the last 90 days. Morningstar still describes the stock as undervalued and keeps its fair value estimate at $64. On that estimate, the stock trades roughly 30% below fair value, which helps explain why the post-earnings pullback has attracted attention.

That backdrop makes the next report important. Investors are shifting from the headline miss to a broader question: is this a temporary transition quarter, or the start of a more durable improvement in earnings quality?

What may be getting lost after the EPS miss

The market may still be valuing the old ESAB mix

A big part of the bull case is that ESAB is no longer the business it was a few years ago. Management says equipment is now over 50% of revenue, up from 38% historically, and the company says that shift has expanded gross margins by about 500 basis points. If the market is still underwriting ESAB like the old equipment-light model, it may be underpricing the change in the earnings mix.

Margin pressure looks real, but it may still be transitional

The cleaner bear case is not the EPS miss by itself. It is the current margin pressure. ESAB said higher logistics and commodity costs created price/cost neutrality that it expects to address through upcoming price and cost-out actions. That is a legitimate watchpoint, but it is different from concluding that the new mix or the broader strategy has stopped working.

The same transition question also surrounds Eddyfi. Management has said the acquisition expands the company's footprint in inspection and monitoring, but investors still need proof that the deal can support growth and margins rather than simply add complexity.

Why the next report matters more than the headline miss

The next report is August 6, 2026. The key question is not whether EPS beats or misses again. It is whether sales momentum persists, whether gross margin improves as management expects, and whether integration and cost actions stay on track.

That is also where behavior can distort pricing. Once a market locks onto an EPS miss, follow-up details about mix and margin often get underplayed. In ESAB's case, that could mean missing a re-rating setup if the underlying business is improving faster than the stock price implies.

What would justify the discount, and what would break it

After the latest revenue beat and the EPS miss, a roughly 30% discount only makes sense if you believe the market is right to stay skeptical. The practical buy trigger is a quarter that shows the prior sales momentum is carrying forward while the margin bridge looks manageable.

If that happens, the story can shift from "profit miss" to "transition working." If instead ESAB shows persistent margin slippage, softer demand commentary, or a messy Eddyfi acquisition integration, then the discount may be closer to a fair warning than a market mistake.